Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10756782rdf:typepubmed:Citationlld:pubmed
pubmed-article:10756782lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10756782lifeskim:mentionsumls-concept:C0028754lld:lifeskim
pubmed-article:10756782lifeskim:mentionsumls-concept:C0242339lld:lifeskim
pubmed-article:10756782pubmed:issue3-4lld:pubmed
pubmed-article:10756782pubmed:dateCreated2000-5-19lld:pubmed
pubmed-article:10756782pubmed:abstractTextThere are multiple lipids anomalies on diabetes. IDDM has, because of insulin lack, raised levels of triglycerides and afferent lipoproteins. NIDDM, especially the obese one, directly linked with insulin-resistance and hyperinsulinemia, has different and complex anomalies. There is a specific type named "B phenotype" with high cardiovascular risk: raised LDL chol charged with TG and low level of HDL chol. Our study on 58 cases with NIDDM obese concluded that only 28% had high TG levels but 71.8% had low levels of HDL chol. We administered fibrates, therapeutical doses, 3 months. We made lipidograms from the beginning and after one and three months. So we proved the good effect of fibrates on lipids: rise of HDL chol., moderate effect on LDL chol. for reduced cardio-vascular risk. There were good results on glucose tolerability (improving 65.8%, p < 0.01).lld:pubmed
pubmed-article:10756782pubmed:languagerumlld:pubmed
pubmed-article:10756782pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:citationSubsetIMlld:pubmed
pubmed-article:10756782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10756782pubmed:statusMEDLINElld:pubmed
pubmed-article:10756782pubmed:issn0048-7848lld:pubmed
pubmed-article:10756782pubmed:authorpubmed-author:UngureanuDDlld:pubmed
pubmed-article:10756782pubmed:authorpubmed-author:PalerMMlld:pubmed
pubmed-article:10756782pubmed:authorpubmed-author:CojocaruMMlld:pubmed
pubmed-article:10756782pubmed:authorpubmed-author:PetrovanuRRlld:pubmed
pubmed-article:10756782pubmed:authorpubmed-author:ComanAAlld:pubmed
pubmed-article:10756782pubmed:issnTypePrintlld:pubmed
pubmed-article:10756782pubmed:volume101lld:pubmed
pubmed-article:10756782pubmed:ownerNLMlld:pubmed
pubmed-article:10756782pubmed:authorsCompleteYlld:pubmed
pubmed-article:10756782pubmed:pagination120-2lld:pubmed
pubmed-article:10756782pubmed:dateRevised2011-1-13lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:meshHeadingpubmed-meshheading:10756782...lld:pubmed
pubmed-article:10756782pubmed:articleTitle[Antilipemic therapy in dyslipidemias in obese non-insulin-dependent diabetics (ONIDDM)].lld:pubmed
pubmed-article:10756782pubmed:affiliationDisciplina Medicin? Intern? de Ambulator, Facultatea de Medicin?, Universitatea de Medicin? ?i Farmacie Gr. T. Popa, Ia?i.lld:pubmed
pubmed-article:10756782pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10756782pubmed:publicationTypeEnglish Abstractlld:pubmed